Technical420 Site Search

MONTREAL, Feb. 28, 2023 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, today announced that it has…

Although 2022 was a challenging year for the cannabis sector, we believe the selloff was overdone and expect the industry to report record sales numbers in 2023. The last few weeks of 2022 were especially challenging for the cannabis sector and we attribute the weakness to the Secure and Fair…

MONTREAL, Jan. 23, 2023 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices  with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced its fiscal first quarter 2023 financial and…

MONTREAL, Nov. 30, 2022 /CNW/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, today announced that the Company filed with the TSX Venture Exchange ("the…

A few months ago, we published an article on Cannara Biotech Inc. (TSX Venture: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated Canadian Licensed Producer (LP) with more than 1.6 million square feet of production capacity.  After the Canadian LP reported earnings, we wanted to issue a follow up article…

MONTREAL, Nov. 25, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced its fiscal fourth quarter and fiscal year 2022 financial and operating results…

With only a few months left in 2022, we have been focused on identifying cannabis companies which are positioned to record strong growth in 2023 and beyond. Although the last year has been challenging for the cannabis sector, we believe the industry is reaching an inflection point and want our…

Today, we are fortunate to have Cannara Biotech CFO Nicholas Sosiak with us for an interview. During the last year, the leading Canadian cannabis company has reported a series of major developments and we believe the business is well positioned to record strong growth in 2023 and beyond. Thank you…

Although 2022 has been a challenging year for the global cannabis industry, we believe the weakness has created a great opportunity to invest in operators which are undervalued and have visible growth prospects. When we analyze a North American cannabis business, we look for operators that meet the following criteria:…

MONTREAL, Sept. 1, 2022 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative products with one of the largest indoor cannabis cultivation facilities in Canada and the largest in Quebec, announced that on August 31, 2022, Derek Stern, a director and principle shareholder owning more…